Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived stem cells + platelet-rich plasma
- Development stage
- Unknown
- Lead developer
- VNUHCM-US Stem Cell Institute (University of Science, VNUHCM)
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
This investigational cell therapy consists of autologous adipose-derived stem cells (ADSCs) in the form of non-expanded stromal vascular fraction (SVF) combined with activated platelet-rich plasma (PRP). Developed through a collaboration involving the University of Science Ho Chi Minh City, Van Hanh General Hospital, Nguyen Tri Phuong Hospital, and GeneWorld Ltd Co, the therapy is being evaluated for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD). The SVF is isolated from the patient's own adipose tissue, while the PRP is obtained from their peripheral blood. The treatment is administered intravenously, leveraging the immunomodulatory and anti-inflammatory properties of mesenchymal stem cells to reduce the chronic inflammation and airflow obstruction characteristic of COPD.
- Other names
- adipose-derived stem cells-University of Science Ho Chi Minh City-chronic obstructive pulmonary diseaseAutologous ADSCs and PRP for COPDSVF + PRP therapyAdipose derived stem cells
Beyond the preview
Go deeper on autologous adipose-derived stem cells + platelet-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived stem cells + platelet-rich plasma.